Caitlin C Murphy1, Kristin Wallace2, Robert S Sandler3, John A Baron3. 1. Departments of Clinical Sciences and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas. Electronic address: caitlin.murphy@utsouthwestern.edu. 2. Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina. 3. Department of Epidemiology and Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Abstract
BACKGROUND & AIMS: Increasing rates of young-onset colorectal cancer (CRC) have attracted substantial research and media attention, but we know little about racial disparities among younger adults with CRC. We examined racial disparities in young-onset CRC by comparing CRC incidence and relative survival among younger (<50-year-old) adults in 2 time periods. METHODS: Using data from the Surveillance, Epidemiology, and End Results program of cancer registries, we estimated CRC incidence rates (per 100,000 persons 20-49 years old) from 1992 through 2014 for different periods (1992-1996 vs 2010-2014) and races (white vs black). Relative survival was calculated as the ratio of observed survival to expected survival in a comparable cancer-free population. RESULTS: From 1992-1996 to 2010-2014, CRC incidence increased from 7.5 to 11.0 per 100,000 in white individuals and from 11.7 to 12.7 per 100,000 in black individuals. The increase in rectal cancer was larger in whites (from 2.7 to 4.5 per 100,000) than in blacks (from 3.4 to 4.0 per 100,000); in the 2010-2014 period, blacks and whites had similar rates of rectal cancer. Compared with whites, blacks had smaller increases in relative survival with proximal colon cancer but larger increases in survival with rectal cancer (from 55.3% to 70.8%). CONCLUSION: In an analysis of the Surveillance, Epidemiology, and End Results database, we found racial disparities in incidence of young-onset CRC and patient survival for cancer of the colon but minimal difference for rectal cancer. Well-documented and recent increases in young-onset CRC have largely been due to increases in rectal cancer, especially in whites.
BACKGROUND & AIMS: Increasing rates of young-onset colorectal cancer (CRC) have attracted substantial research and media attention, but we know little about racial disparities among younger adults with CRC. We examined racial disparities in young-onset CRC by comparing CRC incidence and relative survival among younger (<50-year-old) adults in 2 time periods. METHODS: Using data from the Surveillance, Epidemiology, and End Results program of cancer registries, we estimated CRC incidence rates (per 100,000 persons 20-49 years old) from 1992 through 2014 for different periods (1992-1996 vs 2010-2014) and races (white vs black). Relative survival was calculated as the ratio of observed survival to expected survival in a comparable cancer-free population. RESULTS: From 1992-1996 to 2010-2014, CRC incidence increased from 7.5 to 11.0 per 100,000 in white individuals and from 11.7 to 12.7 per 100,000 in black individuals. The increase in rectal cancer was larger in whites (from 2.7 to 4.5 per 100,000) than in blacks (from 3.4 to 4.0 per 100,000); in the 2010-2014 period, blacks and whites had similar rates of rectal cancer. Compared with whites, blacks had smaller increases in relative survival with proximal colon cancer but larger increases in survival with rectal cancer (from 55.3% to 70.8%). CONCLUSION: In an analysis of the Surveillance, Epidemiology, and End Results database, we found racial disparities in incidence of young-onset CRC and patient survival for cancer of the colon but minimal difference for rectal cancer. Well-documented and recent increases in young-onset CRC have largely been due to increases in rectal cancer, especially in whites.
Authors: Fatemeh Momen-Heravi; Ana Babic; Shelley S Tworoger; Libin Zhang; Kana Wu; Stephanie A Smith-Warner; Shuji Ogino; Andrew T Chan; Jeffrey Meyerhardt; Edward Giovannucci; Charles Fuchs; Eunyoung Cho; Dominique S Michaud; Meir J Stampfer; Yau-Hua Yu; David Kim; Xuehong Zhang Journal: Int J Cancer Date: 2016-11-23 Impact factor: 7.396
Authors: Angela B Mariotto; Anne-Michelle Noone; Nadia Howlader; Hyunsoon Cho; Gretchen E Keel; Jessica Garshell; Steven Woloshin; Lisa M Schwartz Journal: J Natl Cancer Inst Monogr Date: 2014-11
Authors: Frank A Sinicrope; Nathan R Foster; Greg Yothers; Al Benson; Jean Francois Seitz; Roberto Labianca; Richard M Goldberg; Aimery Degramont; Michael J O'Connell; Daniel J Sargent Journal: Cancer Date: 2013-01-10 Impact factor: 6.860
Authors: Hanna K Sanoff; Daniel J Sargent; Erin M Green; Howard L McLeod; Richard M Goldberg Journal: J Clin Oncol Date: 2009-07-27 Impact factor: 44.544
Authors: Esther K Wei; Edward Giovannucci; Kana Wu; Bernard Rosner; Charles S Fuchs; Walter C Willett; Graham A Colditz Journal: Int J Cancer Date: 2004-01-20 Impact factor: 7.396
Authors: Kristin Wallace; Hong Li; J Grant Brazeal; David N Lewin; Shaoli Sun; Aissatou Ba; Chrystal M Paulos; Saleh Rachidi; Zihai Li; Alexander V Alekseyenko Journal: Cancer Epidemiol Date: 2020-06-07 Impact factor: 2.984
Authors: Eric E Low; Joshua Demb; Lin Liu; Ashley Earles; Ranier Bustamante; Christina D Williams; Dawn Provenzale; Tonya Kaltenbach; Andrew J Gawron; Maria Elena Martinez; Samir Gupta Journal: Gastroenterology Date: 2020-01-09 Impact factor: 22.682
Authors: Matthew Devall; Xiangqing Sun; Fangcheng Yuan; Gregory S Cooper; Joseph Willis; Daniel J Weisenberger; Graham Casey; Li Li Journal: J Natl Cancer Inst Date: 2020-12-30 Impact factor: 13.506